Diseases
The Lyme disease pipeline is abuzz with activity as numerous companies work tirelessly to develop effective treatment therapies. According to a recent report by DelveInsight, the Lyme disease pipeline consists of 7+ key companies, with 7+ Lyme disease treatment therapies in various stages of clinical development. The report provides an
Cancer research
Research conducted at the Institute of Cancer Research in London, UK, has shed light on the potential benefits of combining immunotherapy and radiotherapy in treating cancer. According to a recent study published in The Cancer Journal, understanding how tumors evolve in the context of the immune system could provide a
Cancer research
The Advanced Kidney Cancer pipeline landscape is marked by 50+ companies and 55+ pipeline drugs, with a majority of these therapies in various stages of clinical trials. AstraZeneca's Savolitinib and Bristol-Myers Squibb's Relatlimab are among the notable pipeline drugs for Advanced Kidney Cancer treatment. The pipeline
Cancer research
The Thyroid Cancer pipeline landscape is becoming increasingly diverse, with over 50 active players working to develop more than 50 pipeline therapies for the treatment of Thyroid Cancer. Among the prominent companies emerging in this space are AffyImmune Therapeutics, Suzhou Zelgen Biopharmaceuticals, Bristol-Myers Squibb, Suzhou NeuPharma, and AstraZeneca. These companies
Cancer research
DelveInsight's "Advanced Ovarian Cancer Pipeline Insight 2025" report provides comprehensive insights into the dynamic landscape of 50+ companies and 50+ pipeline drugs in advanced ovarian cancer. The report delves into the clinical and nonclinical stage products, therapeutic assessment by product type, stage, route of administration, and
Diseases
A comprehensive pipeline analysis highlights the dynamic landscape of cell and gene therapies for Parkinson's disease, with over 20 therapeutic candidates under investigation by 18+ leading companies. The therapies are in various stages of development, from early-stage pre-clinical candidates to late-stage products nearing market approval. The pipeline includes
Cancer research
DelveInsight's report provides a comprehensive analysis of the relapsed/refractory acute myeloid leukemia (AML) pipeline landscape, covering the development of 75+ therapies for the treatment of relapsed/refractory AML. The report highlights the presence of 50+ companies, including Ascentage Pharma, Cullinan Oncology, Kronos Bio, and Maxinovel Pharmaceuticals, among
Cancer research
A new study published in the Journal of the American Medical Association Network Open highlights the significance of patient navigation in promoting lung cancer screening (LCS) in homeless populations. Researchers from Massachusetts General Hospital conducted a subgroup analysis of the Investigating Navigation to Help Advance Lung Equity (INHALE) pragmatic randomized
Cancer research
The Anaplastic Thyroid Cancer pipeline report provides insights into the latest therapies and clinical trials for the treatment of Anaplastic Thyroid Cancer. The report reveals that there are 8+ active players working on 8+ pipeline therapies for Anaplastic Thyroid Cancer treatment. The leading companies in the Anaplastic Thyroid Cancer pipeline
Cancer research
Researchers at Obstetrics & Gynecology Hospital of Fudan University are conducting a Phase 2 clinical trial to evaluate the efficacy and safety of a novel combination therapy for early-stage cervical cancer patients. The trial involves 20 participants from the USA and combines the antibody Ivonescimab with chemotherapy drugs paclitaxel and
Cancer research
A study published in Health Affairs has found that the FDA's benefit-risk framework for cancer drugs has identified significant uncertainties in new cancer drug approvals. The researchers, led by the London School of Economics and Political Science, analyzed 52 new cancer drug approvals between 2019 and 2022 and
Diseases
Crohn's disease is a chronic inflammatory condition that affects the gastrointestinal tract, causing inflammation and symptoms such as abdominal pain, diarrhea, fatigue, weight loss, and malnutrition. Despite current treatments, there is still a need for effective therapies to manage symptoms and improve quality of life for patients. DelveInsight&
